# Muscle Metastasis as an Atypical Presentation of Non-small Cell Lung Cancer: A Case Report and Literature Review

**Authors:** Fatima Rezzoug, Jihane Derfoufi, Ouissam Al Jarroudi, Sami Aziz Brahmi, Said Afqir

PMC · DOI: 10.7759/cureus.86338 · 2025-06-19

## TL;DR

A rare case of non-small cell lung cancer presenting as a gluteal muscle metastasis is reported, emphasizing the importance of imaging and immunohistochemistry for diagnosis.

## Contribution

This case report highlights the atypical presentation of NSCLC as a muscle metastasis and underscores the diagnostic value of multidisciplinary approaches.

## Key findings

- Gluteal muscle metastasis can be the initial manifestation of NSCLC, preceding primary tumor detection.
- Immunohistochemistry and imaging are crucial for diagnosing atypical soft tissue lesions.
- Multidisciplinary discussion is essential for managing rare metastatic presentations.

## Abstract

Skeletal muscle metastases from non-small cell lung cancer (NSCLC) are rare and often clinically silent, representing an uncommon site of disease dissemination and accounting for approximately 2.3% of cases. Diagnosis is frequently delayed due to nonspecific symptoms and imaging findings that can mimic benign conditions.

We report the case of a 64-year-old man with a history of chronic smoking who presented with right gluteal pain and swelling. Imaging revealed a soft tissue mass within the gluteus maximus muscle. Histopathological analysis of a biopsy specimen demonstrated a poorly differentiated adenocarcinoma. Immunohistochemical staining was positive for CK7 and TTF-1 and negative for CK20, PSA, and CDX2, supporting a pulmonary origin. Molecular testing was negative for ALK, ROS1, RET, MET, and EGFR mutations. The patient received first-line chemotherapy with carboplatin and paclitaxel, achieving stable disease. He subsequently developed brain metastases, which were treated with whole-brain radiotherapy, and is currently undergoing second-line treatment with docetaxel.

This case highlights that gluteal muscle metastasis can present as the initial manifestation of NSCLC, preceding the detection of the primary tumor. It underscores the diagnostic value of imaging and immunohistochemistry in characterizing atypical soft tissue lesions. Multidisciplinary discussion is crucial for accurate diagnosis and optimal management of such rare presentations.

## Linked entities

- **Genes:** ALK (ALK receptor tyrosine kinase) [NCBI Gene 238], ROS1 (ROS proto-oncogene 1, receptor tyrosine kinase) [NCBI Gene 6098], RET (ret proto-oncogene) [NCBI Gene 5979], MET (MET proto-oncogene, receptor tyrosine kinase) [NCBI Gene 4233], EGFR (epidermal growth factor receptor) [NCBI Gene 1956]
- **Proteins:** KRT7 (keratin 7), TTF1 (transcription termination factor 1), KRT20 (keratin 20), KLK3 (kallikrein related peptidase 3), CDX2 (caudal type homeobox 2)
- **Chemicals:** carboplatin (PubChem CID 426756), paclitaxel (PubChem CID 36314), docetaxel (PubChem CID 148124)
- **Diseases:** non-small cell lung cancer (MONDO:0005233)

## Full-text entities

- **Genes:** RET (ret proto-oncogene) [NCBI Gene 5979] {aka CDHF12, CDHR16, HSCR1, MEN2A, MEN2B, MTC1}, ROS1 (ROS proto-oncogene 1, receptor tyrosine kinase) [NCBI Gene 6098] {aka MCF3, ROS, c-ros-1}, SLTM (SAFB like transcription modulator) [NCBI Gene 79811] {aka Met}, PLAG1 (PLAG1 zinc finger) [NCBI Gene 5324] {aka PSA, SGPA, SRS4, ZNF912}, CDX2 (caudal type homeobox 2) [NCBI Gene 1045] {aka CDX-3, CDX2/AS, CDX3}, ALK (ALK receptor tyrosine kinase) [NCBI Gene 238] {aka ALK1, CD246, NBLST3}, TTF1 (transcription termination factor 1) [NCBI Gene 7270] {aka TTF-1, TTF-I}, EGFR (epidermal growth factor receptor) [NCBI Gene 1956] {aka ERBB, ERBB1, ERRP, HER1, NISBD2, NNCIS}, KRT20 (keratin 20) [NCBI Gene 54474] {aka CD20, CK-20, CK20, K20, KRT21}, KRT7 (keratin 7) [NCBI Gene 3855] {aka CK7, K2C7, K7, SCL}
- **Diseases:** gluteal pain (MESH:C531783), swelling (MESH:D004487), NSCLC (MESH:D002289), Muscle Metastasis (MESH:D009362), adenocarcinoma (MESH:D000230), tumor (MESH:D009369)
- **Chemicals:** docetaxel (MESH:D000077143), paclitaxel (MESH:D017239), carboplatin (MESH:D016190)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12276792/full.md

---
Source: https://tomesphere.com/paper/PMC12276792